Home › Type 2 Diabetes › Nebraska › Omaha
Pag-aaral pangklinika para sa Type 2 Diabetes sa Omaha, NE
Isang pag-aaral para sa Type 2 Diabetes ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Omaha. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Nagre-recruitPhase 2
- Nebraska Cancer Specialists, Omaha
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Nagre-recruitPhase 3
- Quality Clinical Research - Omaha, Omaha
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
Nagre-recruitPhase 3
- University Of Nebraska Medical Center, Omaha
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Elkhorn · 17 mi ang layo
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Nagre-recruitPhase 3
- Research Site, Omaha
- Research Site, Omaha
Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
Nagre-recruitPhase 2
- University of Nebraska Medical Center, Omaha
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
Nagre-recruitPhase 3
- Research Site, Omaha
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
Nagre-recruitPhase 2
- Velocity Clinical Research, Omaha, Omaha
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Omaha
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
Nagre-recruitPhase 3
- Methodist Phys. Clinic, Omaha
- West Broadway Clinic, Council Bluffs · 4 mi ang layo
Blood Markers of Early Pancreas Cancer
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Unversity of Nebraska Medical Center, Omaha
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
Nagre-recruit
- University of Nebraska Medical Center, Omaha
Pag-aaral para sa Type 2 Diabetes sa ibang lungsod
- San Antonio, TX37 pag-aaral
- Houston, TX31 pag-aaral
- Orlando, FL25 pag-aaral
- Atlanta, GA21 pag-aaral
- San Diego, CA21 pag-aaral
- Boston, MA20 pag-aaral
- Miami, FL20 pag-aaral
- Chicago, IL19 pag-aaral
- Arlington, VA19 pag-aaral
- Los Angeles, CA18 pag-aaral
- Dallas, TX18 pag-aaral
- Columbus, OH17 pag-aaral
Iba pang pag-aaral sa Omaha
- Kanser sa Prostate29 pag-aaral
- Non-Small Cell Lung Cancer25 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser (lahat ng uri)19 pag-aaral
- Colorectal Cancer18 pag-aaral
- Multiple Myeloma17 pag-aaral
- Kanser sa Ovary15 pag-aaral
- Kanser sa Pancreas15 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg15 pag-aaral
- Metastatic Cancer14 pag-aaral
- Non-Hodgkin Lymphoma14 pag-aaral
- Kanser sa Baga13 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.